TCL Archive “Wild West” of Molecular Testing?: Caris Engaged in Aggressive Marketing, Improper Medicare Billing, Lawsuit Alleges August 8, 2014
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive “Leadership Vacuum: At NCI Allows NIH To Look At Reorganization, Varmus Says November 4, 1994